Kinase fusions are frequent in Spitz tumours and spitzoid melanomas
- PMID: 24445538
- PMCID: PMC4084638
- DOI: 10.1038/ncomms4116
Kinase fusions are frequent in Spitz tumours and spitzoid melanomas
Abstract
Spitzoid neoplasms are a group of melanocytic tumours with distinctive histopathological features. They include benign tumours (Spitz naevi), malignant tumours (spitzoid melanomas) and tumours with borderline histopathological features and uncertain clinical outcome (atypical Spitz tumours). Their genetic underpinnings are poorly understood, and alterations in common melanoma-associated oncogenes are typically absent. Here we show that spitzoid neoplasms harbour kinase fusions of ROS1 (17%), NTRK1 (16%), ALK (10%), BRAF (5%) and RET (3%) in a mutually exclusive pattern. The chimeric proteins are constitutively active, stimulate oncogenic signalling pathways, are tumourigenic and are found in the entire biologic spectrum of spitzoid neoplasms, including 55% of Spitz naevi, 56% of atypical Spitz tumours and 39% of spitzoid melanomas. Kinase inhibitors suppress the oncogenic signalling of the fusion proteins in vitro. In summary, kinase fusions account for the majority of oncogenic aberrations in spitzoid neoplasms and may serve as therapeutic targets for metastatic spitzoid melanomas.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4084638/bin/nihms-592987-f0001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4084638/bin/nihms-592987-f0002.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4084638/bin/nihms-592987-f0003.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4084638/bin/nihms-592987-f0004.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4084638/bin/nihms-592987-f0005.gif)
Similar articles
-
Spitz melanoma is a distinct subset of spitzoid melanoma.Mod Pathol. 2020 Jun;33(6):1122-1134. doi: 10.1038/s41379-019-0445-z. Epub 2020 Jan 3. Mod Pathol. 2020. PMID: 31900433 Free PMC article.
-
Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.Pathology. 2016 Feb;48(2):113-31. doi: 10.1016/j.pathol.2015.12.007. Epub 2016 Jan 18. Pathology. 2016. PMID: 27020384 Free PMC article. Review.
-
The spectrum of spitzoid tumours: A clinical study.Australas J Dermatol. 2012 Aug;53(3):211-5. doi: 10.1111/j.1440-0960.2012.00902.x. Epub 2012 Jun 4. Australas J Dermatol. 2012. PMID: 22671697
-
The role of gene fusions in melanocytic neoplasms.J Cutan Pathol. 2019 Nov;46(11):878-887. doi: 10.1111/cup.13521. Epub 2019 Jun 20. J Cutan Pathol. 2019. PMID: 31152596 Review.
-
BRAF, NRAS and HRAS mutations in spitzoid tumours and their possible pathogenetic significance.Br J Dermatol. 2009 Aug;161(2):364-72. doi: 10.1111/j.1365-2133.2009.09181.x. Epub 2009 Apr 29. Br J Dermatol. 2009. PMID: 19438459
Cited by
-
Gene Expression Profile of Benign, Intermediate, and Malignant Spitz and Spitzoid Melanocytic Lesions.Cancers (Basel). 2024 May 8;16(10):1798. doi: 10.3390/cancers16101798. Cancers (Basel). 2024. PMID: 38791877 Free PMC article.
-
Discovery of 9H-pyrimido[4,5-b]indole derivatives as dual RET/TRKA inhibitors.Bioorg Med Chem. 2024 May 15;106:117749. doi: 10.1016/j.bmc.2024.117749. Epub 2024 May 9. Bioorg Med Chem. 2024. PMID: 38744018
-
Genomic medicine advances for brain tumors.Int J Clin Oncol. 2024 May 10. doi: 10.1007/s10147-024-02522-2. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38727852 Review.
-
Spitz Melanocytic Tumors: A Fascinating 75-Year Journey.Genes (Basel). 2024 Jan 31;15(2):195. doi: 10.3390/genes15020195. Genes (Basel). 2024. PMID: 38397186 Free PMC article. Review.
-
Kinase Fusions in Spitz Melanocytic Tumors: The Past, the Present, and the Future.Dermatopathology (Basel). 2024 Feb 14;11(1):112-123. doi: 10.3390/dermatopathology11010010. Dermatopathology (Basel). 2024. PMID: 38390852 Free PMC article. Review.
References
-
- Ludgate MW, et al. The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution. Cancer. 2009;115:631–41. - PubMed
-
- Murali R, et al. Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so-called atypical spitzoid tumors). Ann Surg Oncol. 2008;15:302–9. - PubMed
-
- Flaherty KT, Hodi FS, Fisher DE. From genes to drugs: targeted strategies for melanoma. Nature reviews. Cancer. 2012;12:349–61. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials